Related Experiment Video
Updated: Feb 4, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
MiR-125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK-STAT3 pathway
1Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Abstract:
The microRNA (miRNA) miR-125b is abnormally expressed in many different types of tumors, including osteosarcoma (OS). How aberrantly expressed miR-125b participates in regulating the initiation and progression of OS is still poorly understood. In the current study, we found that in OS, miR-125b can suppress the expression of MAP kinase kinase 7 (MKK7), which can dephosphorylate and inactivate signal transducer and activator of transcription 3 (STAT3). We also identified an elevated expression level of MKK7 in OS and an association between MKK7 expression and poor prognosis. Further, miR-125b inhibited OS cell proliferation and invasion by targeting and downregulating MKK7 in vitro and suppressed tumor formation in vivo. Moreover, using Western blot analysis, we preliminarily proved that the activation (phosphorylation) of STAT3 was regulated by MKK7 at the epigenetic level. MKK7 was overexpressed in OS and associated with poor clinical results. The miR-125b-MAPK-STAT3 axis may be one of the mechanisms of OS oncogenesis and a potential target for the treatment of OS.
Insights
MicroRNA miR-125b suppresses osteosarcoma (OS) growth by targeting MKK7, which regulates STAT3. This miR-125b-MKK7-STAT3 pathway is crucial in OS development and offers a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNA miR-125b is frequently dysregulated in various cancers, including osteosarcoma (OS).
- The precise role of miR-125b in OS initiation and progression remains unclear.
- Signal transducer and activator of transcription 3 (STAT3) is implicated in cancer development.
Purpose of the Study:
- To elucidate the function of miR-125b in osteosarcoma.
- To investigate the molecular mechanisms by which miR-125b influences OS progression.
- To identify potential therapeutic targets for OS treatment.
Main Methods:
- In vitro assays to assess cell proliferation and invasion.
- In vivo studies to evaluate tumor formation.
- Western blot analysis to examine protein expression and phosphorylation.
- Analysis of MKK7 expression in OS tissues and correlation with prognosis.
Main Results:
- miR-125b directly suppresses MAP kinase kinase 7 (MKK7) expression in OS cells.
- MKK7 dephosphorylates and inactivates STAT3.
- Overexpression of MKK7 in OS correlates with poor prognosis.
- miR-125b inhibits OS cell proliferation, invasion, and tumor growth by downregulating MKK7.
- MKK7 influences STAT3 activation at an epigenetic level.
Conclusions:
- The miR-125b-MKK7-STAT3 axis is a key pathway in osteosarcoma oncogenesis.
- miR-125b acts as a tumor suppressor in OS by targeting MKK7.
- This pathway represents a promising therapeutic target for osteosarcoma treatment.
Related Concept Videos
MAPK Signaling Cascades
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Other Glycolytic Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Respiration Pathways

